|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
DE3438830A1
(de)
|
1984-10-23 |
1986-04-30 |
Rentschler Arzneimittel |
Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
|
|
JPH03204875A
(ja)
*
|
1989-10-03 |
1991-09-06 |
Wakamoto Pharmaceut Co Ltd |
テトラゾール酢酸誘導体、及び該誘導体を有効成分とするアルドースレダクターゼ阻害剤
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
KR0182801B1
(ko)
|
1991-04-16 |
1999-05-01 |
아만 히데아키 |
고체 분산체의 제조방법
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
JP3265680B2
(ja)
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
DE19504832A1
(de)
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
ATE364374T1
(de)
|
1997-08-11 |
2007-07-15 |
Pfizer Prod Inc |
Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
|
|
WO2000001389A1
(en)
|
1998-07-06 |
2000-01-13 |
Bristol-Myers Squibb Co. |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
DE10306502B4
(de)
*
|
2003-02-17 |
2005-03-17 |
Aventis Pharma Deutschland Gmbh |
Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
|
|
KR100869616B1
(ko)
|
2004-05-12 |
2008-11-21 |
화이자 프로덕츠 인코포레이티드 |
프롤린 유도체 및 그의 다이펩티딜 펩티다제－ｉｖ저해제로서의 용도
|
|
JP5190448B2
(ja)
|
2006-04-20 |
2013-04-24 |
ファイザー・プロダクツ・インク |
グルコキナーゼ仲介疾患を予防および治療するための縮合フェニルアミド複素環化合物
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
JP5596026B2
(ja)
*
|
2008-06-19 |
2014-09-24 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェン又はチアゾール誘導体及びｐｉ３ｋ阻害剤としてのそれらの使用
|
|
EP2318370A1
(en)
|
2008-07-29 |
2011-05-11 |
Pfizer Inc. |
Fluorinated heteroaryls
|
|
MY155418A
(en)
|
2008-08-28 |
2015-10-15 |
Pfizer |
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
|
|
EP2332375B1
(en)
|
2008-09-29 |
2018-08-15 |
Nokia Solutions and Networks Oy |
Apparatus, method, system and program for power control or power setting
|
|
WO2010086820A1
(en)
|
2009-02-02 |
2010-08-05 |
Pfizer Inc. |
4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
|
|
MY151246A
(en)
|
2009-03-11 |
2014-04-30 |
Pfizer |
Benzofuranyl derivatives
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
CA2759843A1
(en)
|
2009-05-08 |
2010-11-10 |
Pfizer Inc. |
Gpr 119 modulators
|
|
WO2010128414A1
(en)
|
2009-05-08 |
2010-11-11 |
Pfizer Inc. |
Gpr 119 modulators
|
|
NZ596467A
(en)
|
2009-06-05 |
2014-01-31 |
Pfizer |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
|
WO2011005611A1
(en)
|
2009-07-09 |
2011-01-13 |
Merck Sharp & Dohme Corp. |
Neuromedin u receptor agonists and uses thereof
|
|
EP2954780A1
(en)
|
2009-07-24 |
2015-12-16 |
Baylor College Of Medicine |
Methods of modulation of branched chain acids and uses thereof
|
|
WO2011073298A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Neurosearch A/S |
Tetrazole derivatives as nicotinic acetylcholine receptor modulators
|
|
CN103619836A
(zh)
*
|
2011-03-03 |
2014-03-05 |
德诺瓦姆德有限公司 |
抗菌剂/抗菌佐剂化合物及其方法
|
|
CN108779495A
(zh)
*
|
2016-04-06 |
2018-11-09 |
雀巢产品技术援助有限公司 |
调节bckdh的方法
|
|
EP3555064B9
(en)
|
2016-12-16 |
2023-03-01 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|